Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | IDO1 | P14902 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.33 |
| ▸ | AGXT | P21549 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3341648 | 0.76 | TP53 (0.42) | LTA4HTSHRALDH1A1TP53TRPA1 | |
| SCHEMBL2804442 | 0.76 | TP53 (0.42) | LTA4HTSHRALDH1A1TP53TRPA1 | |
| SCHEMBL104953 | 0.76 | TP53 (0.42) | LTA4HTSHRALDH1A1TP53TRPA1 | |
| SCHEMBL109029 | 0.74 | TSHR (0.41) | LTA4HTSHRALDH1A1TP53CALM1 | |
| SCHEMBL534142 | 0.74 | TSHR (0.41) | LTA4HTSHRALDH1A1TP53CALM1 | |
| SCHEMBL15301959 | 0.73 | TSHR (0.43) | TSHRALDH1A1TP53TRPA1CALM1 | |
| SCHEMBL2202415 | 0.73 | LTA4H (0.39) | LTA4HTSHRALDH1A1TP53CALM1 | |
| Methylamine SCHEMBL29141165 | 0.73 | IDO1 (0.39) | LTA4HTSHRALDH1A1TP53CALM1 | |
| SCHEMBL9505647 | 0.73 | LTA4H (0.39) | LTA4HTSHRALDH1A1TP53TRPA1 | |
| SCHEMBL534035 | 0.73 | TP53 (0.44) | LTA4HTSHRALDH1A1TP53TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2386561-B1 | Methods for producing alkoxyhydrosilanes | KANEKA CORP (JP) | 2016-01-13 | — | — | EP | disclosed |
| EP-2392600-B1 | Polymer having a reactive silicon-containing group, methods for its preparation and a curable composition comprising the polymer | KANEKA CORP (JP) | 2015-12-23 | — | — | EP | disclosed |
| EP-2586784-B1 | METHOD FOR PRODUCING ALKOXY HYDROSILANE | KANEKA CORP (JP) | 2015-12-09 | — | — | EP | disclosed |
| EP-2586783-B1 | METHOD FOR PRODUCING ALKOXY HYDROSILANE | KANEKA CORP (JP) | 2015-08-05 | — | — | EP | disclosed |
| EP-2586783-A1 | METHOD FOR PRODUCING ALKOXY HYDROSILANE | Kaneka Corporation (JP) | 2013-05-01 | — | — | EP | disclosed |
| EP-2586784-A1 | METHOD FOR PRODUCING ALKOXY HYDROSILANE | Kaneka Corporation (JP) | 2013-05-01 | — | — | EP | disclosed |
| US-20120196981-A1 | METHOD FOR PRODUCING a-HETERO-SUBSTITUTED ALKYLHALOHYDROSILANE AND USE THEREOF | KANEKACORPORATION (JP) | 2012-08-02 | — | — | US | disclosed |
| EP-2392600-A1 | Polymer having a reactive silicon-containing group, methods for its preparation and a curable composition comprising the polymer | Kaneka Corporation (JP) | 2011-12-07 | — | — | EP | disclosed |
| EP-2386561-A1 | Methods for producing alkoxyhydrosilanes | Kaneka Corporation (JP) | 2011-11-16 | — | — | EP | disclosed |
| US-8039142-B2 | Battery case | SONY CORPORATION (JP) | 2011-10-18 | — | — | US | disclosed |
| US-20110207886-A1 | Method for Producing a-hereto-Substituted Alkylhalohydrosilane and Use Thereof | KANEKA CORPORATION (JP) | 2011-08-25 | — | — | US | disclosed |
| EP-2308884-A1 | METHOD FOR PRODUCING -HETERO-SUBSTITUTED ALKYLHALOHYDROSILANE AND USE THEREOF | Kaneka Corporation (JP) | 2011-04-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120196981-A1 | METHOD FOR PRODUCING a-HETERO-SUBSTITUTED ALKYLHALOHYDROSILANE AND USE THEREOF | ARSA, HACL2, AS3MT | LTA4H 2608/4885TSHR 3146/4885ALDH1A1 2288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.